Lung abscess by

Fusobacterium nucleatum Streptococcus spp. co-infection lung abscess shotgun metagenome next-generation sequencing

Journal

Open life sciences
ISSN: 2391-5412
Titre abrégé: Open Life Sci
Pays: Poland
ID NLM: 101669614

Informations de publication

Date de publication:
2023
Historique:
received: 14 02 2023
revised: 15 05 2023
accepted: 05 06 2023
medline: 24 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

A lung abscess is a necrotizing infection caused by microbiomes that lead to the loss of healthy lung tissue. The routine culture is a waste of time and yields false-negative results, and clinicians could only choose empiric therapy or use broad-spectrum antibiotics, which could significantly contribute to the problem of resistance or aggravate the condition. We report three patients with a routine-culture-negative lung abscess. The presenting symptoms included fever, cough, dyspnea, and chest pain, and a computed tomography scan revealed a lesion in the lungs. The bronchoalveolar lavage fluid and pleural fluid were tested for pathogens using metagenome next-generation sequencing (mNGS), and the results revealed

Identifiants

pubmed: 37483431
doi: 10.1515/biol-2022-0651
pii: biol-2022-0651
pmc: PMC10358748
doi:

Types de publication

Case Reports

Langues

eng

Pagination

20220651

Informations de copyright

© 2023 the author(s), published by De Gruyter.

Déclaration de conflit d'intérêts

Conflict of interest: Xiaolin Liu is employed by the company Liaoning Kanghui Biotechnology Co., Ltd. All authors declare that they have no conflict of interest.

Références

Mol Microbiol. 2009 Jan;71(1):35-47
pubmed: 19007407
Nat Rev Microbiol. 2019 Mar;17(3):156-166
pubmed: 30546113
BMC Infect Dis. 2020 May 18;20(1):351
pubmed: 32423417
Ann Transplant. 2021 Jun 08;26:e931059
pubmed: 34099614
Intern Med. 2022 Jul 15;61(14):2227-2232
pubmed: 34980794
J Bras Pneumol. 2006 Mar-Apr;32(2):136-43
pubmed: 17273583
J Osteopath Med. 2022 Jul 14;122(10):493-497
pubmed: 35822717
Eur Radiol. 2022 Feb;32(2):1184-1194
pubmed: 34327579
Am J Ther. 2014 May-Jun;21(3):217-21
pubmed: 22248872
Microbes Infect. 2000 Oct;2(12):1425-30
pubmed: 11099928
Microbiol Immunol. 1999;43(3):207-16
pubmed: 10338189
N Engl J Med. 2014 Jun 19;370(25):2408-17
pubmed: 24896819
Thorac Surg Clin. 2022 Aug;32(3):349-360
pubmed: 35961743
Arch Pathol Lab Med. 2017 Jun;141(6):776-786
pubmed: 28169558
CMAJ. 2022 May 9;194(18):E645-E648
pubmed: 35534028
Ann Transl Med. 2015 Aug;3(13):183
pubmed: 26366400
PLoS One. 2018 Apr 17;13(4):e0194648
pubmed: 29664913
J Periodontal Res. 2013 Aug;48(4):493-9
pubmed: 23173872
Clin Microbiol Rev. 2023 Mar 23;36(1):e0011922
pubmed: 36847515
Curr Opin Microbiol. 2015 Feb;23:141-7
pubmed: 25576662
ANZ J Surg. 2022 Jul;92(7-8):1850-1855
pubmed: 35678219
Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):329-336
pubmed: 27771780
Adv Respir Med. 2023 Feb 02;91(1):49-65
pubmed: 36825940
BMC Pulm Med. 2020 Mar 17;20(1):65
pubmed: 32178660
Pneumonol Alergol Pol. 2014;82(3):276-85
pubmed: 24793153
Ophthalmology. 2017 Aug;124(8):1247-1248
pubmed: 28526549

Auteurs

Na Wang (N)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Pharmacology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.

Zhichao Gao (Z)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Breast Medicine, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.

Shuai He (S)

Department of Imaging, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.

Mengzhen Han (M)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Pharmacology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.

Wenjie Han (W)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Pharmacology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.

Xiaolin Liu (X)

Liaoning Kanghui Biotechnology Co., Ltd, Zhihuier Street, Hunnan District, Shenyang, 110001, China.

Hui Cao (H)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Breast Medicine, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.

Mingxi Jing (M)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Breast Medicine, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.

Tao Sun (T)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Breast Medicine, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.

Junnan Xu (J)

Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Pharmacology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Breast Medicine, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, 110042, China.
Department of Medical Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, No. 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning 110042, P. R. China.

Classifications MeSH